在患有骨关节炎的医疗保险受益者中,不同止痛药的使用与高血压之间的关联
Shailina Keshwani1, Haesuk Park1, Wei-Hsuan Lo-Ciganic1,2,3
1Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Journal of the American Geriatrics Society
|March 15, 2026
概括
高血压没有影响骨关节炎的老年人最初选择的止痛药. 需要更多的研究来为患有这两种疾病的人找到更安全的替代品.
科学领域:
- 老年医学 老年医学
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
背景情况:
- 患有骨关节炎 (OA) 和高血压 (HTN) 的老年人面临某些止痛药的心血管风险增加.
- 高血压对骨关节炎初始止痛药选择的影响尚不清楚.
研究的目的:
- 调查高血压是否影响医疗保险受益人诊断出发生性骨关节炎的初始止痛药选择.
- 为了比较骨关节炎患者与并发性高血压患者之间的止痛药处方模式.
主要方法:
- 2011-2022年65岁以上的医疗保险受益人的回顾性队列研究.
- 在诊断后30天内开始服用止痛药的发生性OA患者的分析.
- 通过逻辑回归,使用基线高血压和没有基线高血压的患者 (OA+HTN与仅OA) 之间的止痛药开始的比较.
主要成果:
- 在179,033名受益者中,57.1%的人患有基线高血压.
- 最常见的初始止痛药是关节内注射 (30.3%) 和口服NSAID (28.2%).
- 与口服NSAID相比,在OA+HTN和OA-only组之间没有观察到开始口服阿片类药物,关节内注射或局部NSAID的几率有显著差异.
结论:
- 基线高血压没有影响发生性骨关节炎患者最初的止痛选择.
- 对于患有骨关节炎和高血压并发症的老年人来说,需要更安全,基于证据的止痛替代品.
相关概念视频
Analgesia and Pain Management
2.7K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Hypertension and Regulation of Blood Pressure
4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.8K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K

